270 related articles for article (PubMed ID: 32176452)
1. Iron protects childhood acute lymphoblastic leukemia cells from methotrexate cytotoxicity.
Abedi M; Rahgozar S; Esmaeili A
Cancer Med; 2020 May; 9(10):3537-3550. PubMed ID: 32176452
[TBL] [Abstract][Full Text] [Related]
2. Differential methotrexate resistance in childhood T- versus common/preB-acute lymphoblastic leukemia can be measured by an in situ thymidylate synthase inhibition assay, but not by the MTT assay.
Rots MG; Pieters R; Kaspers GJ; van Zantwijk CH; Noordhuis P; Mauritz R; Veerman AJ; Jansen G; Peters GJ
Blood; 1999 Feb; 93(3):1067-74. PubMed ID: 9920857
[TBL] [Abstract][Full Text] [Related]
3. Selective dysregulation of ABC transporters in methotrexate-resistant leukemia T-cells can confer cross-resistance to cytarabine, vincristine and dexamethasone, but not doxorubicin.
Aberuyi N; Rahgozar S; Pourabutaleb E; Ghaedi K
Curr Res Transl Med; 2021 Jan; 69(1):103269. PubMed ID: 33071214
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo resistance in childhood acute lymphoblastic leukemia: Correlations between BCRP, MRP1, MRP4 and MRP5 ABC transporter expression and intracellular methotrexate polyglutamate accumulation.
Jaramillo AC; Cloos J; Lemos C; Stam RW; Kaspers GJL; Jansen G; Peters GJ
Leuk Res; 2019 Apr; 79():45-51. PubMed ID: 30849662
[TBL] [Abstract][Full Text] [Related]
5. The Expression and Activation of the NF-κB Pathway Correlate with Methotrexate Resistance and Cell Proliferation in Acute Lymphoblastic Leukemia.
Canevarolo RR; Cury NM; Yunes JA
Genes (Basel); 2023 Sep; 14(10):. PubMed ID: 37895229
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of SORCIN is a Prognostic Biomarker for Multidrug-Resistant Pediatric Acute Lymphoblastic Leukemia and Correlates with Upregulated MDR1/P-gp.
Dabaghi M; Rahgozar S; Moshtaghian J; Moafi A; Abedi M; Pourabutaleb E
Genet Test Mol Biomarkers; 2016 Sep; 20(9):516-21. PubMed ID: 27382961
[TBL] [Abstract][Full Text] [Related]
7. A single assessment of methotrexate levels at 42 hours permits safe administration and early discharge in children with lymphoblastic lymphoma and leukemia receiving high-dose methotrexate.
Totadri S; Srinivasan HN; Joseph LL; Boddu D; Mathew LG; John R
Pediatr Hematol Oncol; 2021 Aug; 38(5):434-443. PubMed ID: 33764242
[TBL] [Abstract][Full Text] [Related]
8. mRNA expression profile of multidrug-resistant genes in acute lymphoblastic leukemia of children, a prognostic value for ABCA3 and ABCA2.
Rahgozar S; Moafi A; Abedi M; Entezar-E-Ghaem M; Moshtaghian J; Ghaedi K; Esmaeili A; Montazeri F
Cancer Biol Ther; 2014 Jan; 15(1):35-41. PubMed ID: 24145140
[TBL] [Abstract][Full Text] [Related]
9. HSH2D contributes to methotrexate resistance in human T‑cell acute lymphoblastic leukaemia.
Wang J; Xiong Y
Oncol Rep; 2020 Nov; 44(5):2121-2129. PubMed ID: 33000278
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous changes in expression levels of BAALC and miR-326: a novel prognostic biomarker for childhood ALL.
Ghodousi ES; Aberuyi N; Rahgozar S
Jpn J Clin Oncol; 2020 Jun; 50(6):671-678. PubMed ID: 32129446
[TBL] [Abstract][Full Text] [Related]
11. The relationship between iron bone marrow stores and response to treatment in pediatric acute lymphoblastic leukemia.
Moafi A; Ziaie M; Abedi M; Rahgozar S; Reisi N; Nematollahi P; Moafi H
Medicine (Baltimore); 2017 Nov; 96(44):e8511. PubMed ID: 29095311
[TBL] [Abstract][Full Text] [Related]
12. CD123 expression patterns and selective targeting with a CD123-targeted antibody-drug conjugate (IMGN632) in acute lymphoblastic leukemia.
Angelova E; Audette C; Kovtun Y; Daver N; Wang SA; Pierce S; Konoplev SN; Khogeer H; Jorgensen JL; Konopleva M; Zweidler-McKay PA; Medeiros LJ; Kantarjian HM; Jabbour EJ; Khoury JD
Haematologica; 2019 Apr; 104(4):749-755. PubMed ID: 30361418
[TBL] [Abstract][Full Text] [Related]
13. Time course of methotrexate polyglutamate formation and degradation in the pre-B-leukaemia cell line Nalm6 and in lymphoblasts from children with leukaemia.
Buchholz B; Frei E; Eisenbarth J; Weigand M; Ludwig R
Eur J Cancer; 1996 Nov; 32A(12):2101-7. PubMed ID: 9014752
[TBL] [Abstract][Full Text] [Related]
14. Defective transport as a mechanism of acquired resistance to methotrexate in patients with acute lymphocytic leukemia.
Trippett T; Schlemmer S; Elisseyeff Y; Goker E; Wachter M; Steinherz P; Tan C; Berman E; Wright JE; Rosowsky A
Blood; 1992 Sep; 80(5):1158-62. PubMed ID: 1381235
[TBL] [Abstract][Full Text] [Related]
15. Variegated clonality and rapid emergence of new molecular lesions in xenografts of acute lymphoblastic leukemia are associated with drug resistance.
Nowak D; Liem NL; Mossner M; Klaumünzer M; Papa RA; Nowak V; Jann JC; Akagi T; Kawamata N; Okamoto R; Thoennissen NH; Kato M; Sanada M; Hofmann WK; Ogawa S; Marshall GM; Lock RB; Koeffler HP
Exp Hematol; 2015 Jan; 43(1):32-43.e1-35. PubMed ID: 25450514
[TBL] [Abstract][Full Text] [Related]
16. [Therapeutic strategies for childhood high-risk acute lymphoblastic leukemia].
Lu XT
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Apr; 45(2):327-32. PubMed ID: 23591360
[TBL] [Abstract][Full Text] [Related]
17. In vivo response to methotrexate forecasts outcome of acute lymphoblastic leukemia and has a distinct gene expression profile.
Sorich MJ; Pottier N; Pei D; Yang W; Kager L; Stocco G; Cheng C; Panetta JC; Pui CH; Relling MV; Cheok MH; Evans WE
PLoS Med; 2008 Apr; 5(4):e83. PubMed ID: 18416598
[TBL] [Abstract][Full Text] [Related]
18. Ginger extract has anti-leukemia and anti-drug resistant effects on malignant cells.
Rahimi Babasheikhali S; Rahgozar S; Mohammadi M
J Cancer Res Clin Oncol; 2019 Aug; 145(8):1987-1998. PubMed ID: 31214760
[TBL] [Abstract][Full Text] [Related]
19. Multiple drug resistance protein (MDR-1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) gene expression in childhood acute lymphoblastic leukemia.
Valera ET; Scrideli CA; Queiroz RG; Mori BM; Tone LG
Sao Paulo Med J; 2004 Jul; 122(4):166-71. PubMed ID: 15543372
[TBL] [Abstract][Full Text] [Related]
20. Investigating chemoresistance to improve sensitivity of childhood T-cell acute lymphoblastic leukemia to parthenolide.
Ede BC; Asmaro RR; Moppett JP; Diamanti P; Blair A
Haematologica; 2018 Sep; 103(9):1493-1501. PubMed ID: 29773592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]